Showing 1 - 20 results of 29 for search 'Laura Richert', query time: 0.07s
Refine Results
-
1
-
2
Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells by Vera Schwane, Van Hung Huynh-Tran, Sarah Vollmers, Vivien Maria Yakup, Jürgen Sauter, Alexander H. Schmidt, Alexander H. Schmidt, Sven Peine, Marcus Altfeld, Marcus Altfeld, Laura Richert, Laura Richert, Christian Körner
Published 2020-12-01
Article -
3
-
4
Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals by Rodolphe Thiébaut, Rodolphe Thiébaut, Rodolphe Thiébaut, Boris P. Hejblum, Boris P. Hejblum, Boris P. Hejblum, Hakim Hocini, Hakim Hocini, Hakim Hocini, Henri Bonnabau, Henri Bonnabau, Henri Bonnabau, Jason Skinner, Monica Montes, Christine Lacabaratz, Christine Lacabaratz, Christine Lacabaratz, Laura Richert, Laura Richert, Laura Richert, Karolina Palucka, Jacques Banchereau, Yves Lévy, Yves Lévy, Yves Lévy
Published 2019-04-01
Article -
5
No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults. by Jean-Paul Viard, Alex Assuied, Yves Lévy, Jean-Claude Souberbielle, Rodolphe Thiébaut, Fabrice Carrat, Geneviève Chêne, Odile Launay, Laura Richert
Published 2016-01-01
Article -
6
Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy. by Edouard Lhomme, Laura Richert, Zoe Moodie, Chloé Pasin, Spyros A Kalams, Cecilia Morgan, Steve Self, Stephen C De Rosa, Rodolphe Thiébaut
Published 2016-01-01
Article -
7
Identification of early gene expression profiles associated with long-lasting antibody responses to the Ebola vaccine Ad26.ZEBOV/MVA-BN-Filo by Fabiola Blengio, Hakim Hocini, Laura Richert, Cécile Lefebvre, Mélany Durand, Boris Hejblum, Pascaline Tisserand, Chelsea McLean, Kerstin Luhn, Rodolphe Thiebaut, Yves Levy
Published 2023-09-01
Article -
8
Durable natural killer cell responses after heterologous two-dose Ebola vaccination by Helen R. Wagstaffe, Giada Susannini, Rodolphe Thiébaut, Laura Richert, Yves Lévy, Viki Bockstal, Jeroen N. Stoop, Kerstin Luhn, Macaya Douoguih, Eleanor M. Riley, Christine Lacabaratz, Martin R. Goodier
Published 2021-01-01
Article -
9
NK Cell Subset Redistribution and Antibody Dependent Activation after Ebola Vaccination in Africans by Helen R. Wagstaffe, Omu Anzala, Hannah Kibuuka, Zacchaeus Anywaine, Sodiomon B. Sirima, Rodolphe Thiébaut, Laura Richert, Yves Levy, Christine Lacabaratz, Viki Bockstal, Kerstin Luhn, Macaya Douoguih, Martin R. Goodier
Published 2022-05-01
Article -
10
Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context by Edouard Lhomme, Camara Modet, Augustin Augier, Sylvain Faye, Tienhan Sandrine Dabakuyo-Yonli, Claire Levy-Marchal, Eric D’Ortenzio, Yazdan Yazdanpanah, Geneviève Chêne, Abdoul Habib Beavogui, Laura Richert, the PREVAC study team
Published 2019-07-01
Article -
11
HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates. by Anne-Laure Flamar, Henri Bonnabau, Sandra Zurawski, Christine Lacabaratz, Monica Montes, Laura Richert, Aurelie Wiedemann, Lindsey Galmin, Deborah Weiss, Anthony Cristillo, Lauren Hudacik, Andres Salazar, Cécile Peltekian, Rodolphe Thiebaut, Gerard Zurawski, Yves Levy
Published 2018-01-01
Article -
12
Proliferative capacity exhibited by human liver-resident CD49a+CD25+ NK cells. by Glòria Martrus, Tobias Kautz, Sebastian Lunemann, Laura Richert, Laura Glau, Wilhelm Salzberger, Hanna Goebels, Annika Langeneckert, Leonard Hess, Tobias Poch, Christoph Schramm, Karl J Oldhafer, Martina Koch, Eva Tolosa, Björn Nashan, Marcus Altfeld
Published 2017-01-01
Article -
13
Tissue-resident NK cells differ in their expression profile of the nutrient transporters Glut1, CD98 and CD71. by Wilhelm Salzberger, Gloria Martrus, Kai Bachmann, Hanna Goebels, Leonard Heß, Martina Koch, Annika Langeneckert, Sebastian Lunemann, Karl J Oldhafer, Caroline Pfeifer, Tobias Poch, Laura Richert, Christoph Schramm, Ramez Wahib, Madeleine J Bunders, Marcus Altfeld
Published 2018-01-01
Article -
14
Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases by Aurélie Wiedemann, Edouard Lhomme, Mélanie Huchon, Emile Foucat, Marion Bérerd-Camara, Lydia Guillaumat, Marcel Yaradouno, Jacqueline Tambalou, Cécile Rodrigues, Alexandre Ribeiro, Abdoul Habib Béavogui, Christine Lacabaratz, Rodolphe Thiébaut, Laura Richert, Yves Lévy, the Prevac study team
Published 2024-09-01
Article -
15
Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach by Leonie M. Weskamm, Paulina Tarnow, Charlotte Harms, Melanie Huchon, Matthijs P. Raadsen, Monika Friedrich, Laura Rübenacker, Cordula Grüttner, Mariana G. Garcia, Till Koch, Stephan Becker, Gerd Sutter, Edouard Lhomme, Bart L. Haagmans, Anahita Fathi, Sandra M. Blois, Christine Dahlke, Laura Richert, Marylyn M. Addo
Published 2024-08-01
Article -
16
The Transcription Factor Promyelocytic Leukemia Zinc Finger Protein Is Associated With Expression of Liver‐Homing Receptors on Human Blood CD56bright Natural Killer Cells by Leonard U. Hess, Glòria Martrus, Annerose E. Ziegler, Annika E. Langeneckert, Wilhelm Salzberger, Hanna Goebels, Adrian F. Sagebiel, Sven H. Hagen, Tobias Poch, Gevitha Ravichandran, Martina Koch, Christoph Schramm, Karl J. Oldhafer, Lutz Fischer, Gisa Tiegs, Laura Richert, Madeleine J. Bunders, Sebastian Lunemann, Marcus Altfeld
Published 2020-03-01
Article -
17
Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial by Simon Valayer, Marie Alexandre, Mélanie Prague, Abdoul Habib Beavogui, Seydou Doumbia, Mark Kieh, Brian Greenwood, Bailah Leigh, Marie Poupelin, Christine Schwimmer, Samba O. Sow, Irina Maljkovic Berry, Jens H. Kuhn, Daniela Fusco, Natasha Dubois Cauwelaert, Deborah Watson-Jones, Rodolphe Thiébaut, Yves Lévy, Yazdan Yazdanpanah, Laura Richert, Edouard Lhomme
Published 2025-12-01
Article -
18
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical tr... by Houreratou Barry, Gaudensia Mutua, Hannah Kibuuka, Zacchaeus Anywaine, Sodiomon B. Sirima, Nicolas Meda, Omu Anzala, Serge Eholie, Christine Bétard, Laura Richert, Christine Lacabaratz, M. Juliana McElrath, Stephen De Rosa, Kristen W. Cohen, Georgi Shukarev, Cynthia Robinson, Auguste Gaddah, Dirk Heerwegh, Viki Bockstal, Kerstin Luhn, Maarten Leyssen, Macaya Douoguih, Rodolphe Thiébaut, the EBL2002 Study group
Published 2021-10-01
Article -
19
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical tr... by Houreratou Barry, Gaudensia Mutua, Hannah Kibuuka, Zacchaeus Anywaine, Sodiomon B Sirima, Nicolas Meda, Omu Anzala, Serge Eholie, Christine Bétard, Laura Richert, Christine Lacabaratz, M Juliana McElrath, Stephen De Rosa, Kristen W Cohen, Georgi Shukarev, Cynthia Robinson, Auguste Gaddah, Dirk Heerwegh, Viki Bockstal, Kerstin Luhn, Maarten Leyssen, Macaya Douoguih, Rodolphe Thiébaut, EBL2002 Study group
Published 2021-10-01
Article -
20
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phas... by Zacchaeus Anywaine, Houreratou Barry, Omu Anzala, Gaudensia Mutua, Sodiomon B Sirima, Serge Eholie, Hannah Kibuuka, Christine Bétard, Laura Richert, Christine Lacabaratz, M Juliana McElrath, Stephen C De Rosa, Kristen W Cohen, Georgi Shukarev, Michael Katwere, Cynthia Robinson, Auguste Gaddah, Dirk Heerwegh, Viki Bockstal, Kerstin Luhn, Maarten Leyssen, Rodolphe Thiébaut, Macaya Douoguih, EBL2002 Study group
Published 2022-01-01
Article